- Home
- ZEPP vs XGN Comparison
ZEPP vs XGN Comparison
Compare ZEPP & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZEPP | XGN |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.0M | 138.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZEPP | XGN |
|---|---|---|
| Price | $28.16 | $6.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 173.2K | ★ 260.3K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $233,274,000.00 | $63,599,000.00 |
| Revenue This Year | $887.39 | $21.76 |
| Revenue Next Year | $26.12 | $15.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 11.64 | ★ 14.08 |
| 52 Week Low | $2.13 | $2.67 |
| 52 Week High | $61.85 | $12.23 |
Technical Indicators
Market Signals| Indicator | ZEPP | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 26.18 |
| Support Level | $27.45 | $5.93 |
| Resistance Level | $28.95 | $6.34 |
| Average True Range (ATR) | 1.96 | 0.34 |
| MACD | 0.28 | 0.03 |
| Stochastic Oscillator | 41.65 | 14.09 |
Price Performance
Historical ComparisonAbout ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.